Biopharmaceutical firm UCB to invest £1bn in UK for research and development
This article was originally published here
UCB will build a new £150mto £200m research and development facility as part of the total investment over the next five years. The transition to the facility will
The post Biopharmaceutical firm UCB to invest £1bn in UK for research and development appeared first on Pharmaceutical Business review.
Leave a Reply
Want to join the discussion?Feel free to contribute!